These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30029060)

  • 41. Epitope-based DNA vaccine for Alzheimer's disease: translational study in macaques.
    Evans CF; Davtyan H; Petrushina I; Hovakimyan A; Davtyan A; Hannaman D; Cribbs DH; Agadjanyan MG; Ghochikyan A
    Alzheimers Dement; 2014 May; 10(3):284-95. PubMed ID: 23916838
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improved Brain Expression of Anti-Amyloid β scFv by Complexation of mRNA Including a Secretion Sequence with PEG-based Block Catiomer.
    Perche F; Uchida S; Akiba H; Lin CY; Ikegami M; Dirisala A; Nakashima T; Itaka K; Tsumoto K; Kataoka K
    Curr Alzheimer Res; 2017; 14(3):295-302. PubMed ID: 27829339
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nasal inoculation of an adenovirus vector encoding 11 tandem repeats of Abeta1-6 upregulates IL-10 expression and reduces amyloid load in a Mo/Hu APPswe PS1dE9 mouse model of Alzheimer's disease.
    Kim HD; Tahara K; Maxwell JA; Lalonde R; Fukuiwa T; Fujihashi K; Van Kampen KR; Kong FK; Tang DC; Fukuchi K
    J Gene Med; 2007 Feb; 9(2):88-98. PubMed ID: 17219449
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A vaccine against Alzheimer`s disease: anything left but faith?
    Bachmann MF; Jennings GT; Vogel M
    Expert Opin Biol Ther; 2019 Jan; 19(1):73-78. PubMed ID: 30526133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Naturally occurring autoantibodies against beta-amyloid: investigating their role in transgenic animal and in vitro models of Alzheimer's disease.
    Dodel R; Balakrishnan K; Keyvani K; Deuster O; Neff F; Andrei-Selmer LC; Röskam S; Stüer C; Al-Abed Y; Noelker C; Balzer-Geldsetzer M; Oertel W; Du Y; Bacher M
    J Neurosci; 2011 Apr; 31(15):5847-54. PubMed ID: 21490226
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A safer vaccine for Alzheimer's disease?
    Sigurdsson EM; Wisniewski T; Frangione B
    Neurobiol Aging; 2002; 23(6):1001-8. PubMed ID: 12470795
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A multimeric immunogen for the induction of immune memory to beta-amyloid.
    Mantile F; Basile C; Cicatiello V; De Falco D; Caivano A; De Berardinis P; Prisco A
    Immunol Cell Biol; 2011 Jul; 89(5):604-9. PubMed ID: 21102534
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Active immunization of mice with an Abeta-Hsp70 vaccine.
    Koller MF; Mohajeri MH; Huber M; Wollmer MA; Roth Z'graggen BV; Sandmeier E; Moritz E; Tracy J; Nitsch RM; Christen P
    Neurodegener Dis; 2004; 1(1):20-8. PubMed ID: 16908970
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Abeta1-15 is less immunogenic than Abeta1-40/42 for intranasal immunization of wild-type mice but may be effective for "boosting".
    Leverone JF; Spooner ET; Lehman HK; Clements JD; Lemere CA
    Vaccine; 2003 May; 21(17-18):2197-206. PubMed ID: 12706711
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modified immunotherapies against Alzheimer's disease: toward safer and effective amyloid clearance.
    Wang YJ; Zhou HD; Zhou XF
    J Alzheimers Dis; 2010; 21(4):1065-75. PubMed ID: 21504118
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Immunotherapy of Alzheimer's disease. Results of experimental investigations and treatment of perspectives].
    Karkos J
    Fortschr Neurol Psychiatr; 2004 Apr; 72(4):204-19. PubMed ID: 15095177
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vaccines targeting the primary amino acid sequence and conformational epitope of amyloid-β had distinct effects on neuropathology and cognitive deficits in EAE/AD mice.
    Yu XL; Zhu J; Liu XM; Xu PX; Zhang Y; Liu RT
    Br J Pharmacol; 2020 Jun; 177(12):2860-2871. PubMed ID: 32034757
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vaccine-induced Aβ-specific CD8+ T cells do not trigger autoimmune neuroinflammation in a murine model of Alzheimer's disease.
    Rosset MB; Lui G; Dansokho C; Chaigneau T; Dorothée G
    J Neuroinflammation; 2015 May; 12():95. PubMed ID: 25982697
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Active Aβ vaccination fails to enhance amyloid clearance in a mouse model of Alzheimer's disease with Aβ42-driven pathology.
    Nemirovsky A; Shapiro J; Baron R; Kompaniets A; Monsonego A
    J Neuroimmunol; 2012 Jun; 247(1-2):95-9. PubMed ID: 22498096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Short amyloid-β immunogens with spacer-enhanced immunogenicity without junctional epitopes for Alzheimer's disease immunotherapy.
    Guan X; Zou J; Gu H; Yao Z
    Neuroreport; 2012 Oct; 23(15):879-84. PubMed ID: 22922658
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The second-generation active Aβ immunotherapy CAD106 reduces amyloid accumulation in APP transgenic mice while minimizing potential side effects.
    Wiessner C; Wiederhold KH; Tissot AC; Frey P; Danner S; Jacobson LH; Jennings GT; Lüönd R; Ortmann R; Reichwald J; Zurini M; Mir A; Bachmann MF; Staufenbiel M
    J Neurosci; 2011 Jun; 31(25):9323-31. PubMed ID: 21697382
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Methods to monitor monocytes-mediated amyloid-beta uptake and phagocytosis in the context of adjuvanted immunotherapies.
    Hallé M; Tribout-Jover P; Lanteigne AM; Boulais J; St-Jean JR; Jodoin R; Girouard MP; Constantin F; Migneault A; Renaud F; Didierlaurent AM; Mallett CP; Burkhart D; Pilorget A; Palmantier R; Larocque D
    J Immunol Methods; 2015 Sep; 424():64-79. PubMed ID: 26002154
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An Aβ3-10-KLH vaccine reduced Alzheimer's disease-like pathology and had a sustained effect in Tg-APPswe/PSEN1dE9 mice.
    Meng Y; Ding L; Zhang HY; Yin WC; Yan Y; Cao YP
    Brain Res; 2017 Oct; 1673():72-77. PubMed ID: 28779977
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The immunological potency and therapeutic potential of a prototype dual vaccine against influenza and Alzheimer's disease.
    Davtyan H; Ghochikyan A; Cadagan R; Zamarin D; Petrushina I; Movsesyan N; Martinez-Sobrido L; Albrecht RA; García-Sastre A; Agadjanyan MG
    J Transl Med; 2011 Aug; 9():127. PubMed ID: 21806809
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased T cell recruitment to the CNS after amyloid beta 1-42 immunization in Alzheimer's mice overproducing transforming growth factor-beta 1.
    Buckwalter MS; Coleman BS; Buttini M; Barbour R; Schenk D; Games D; Seubert P; Wyss-Coray T
    J Neurosci; 2006 Nov; 26(44):11437-41. PubMed ID: 17079673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.